Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis

BACKGROUND: Myocardial infarction (MI) is a cardiovascular disease with high morbidity and mortality. PI16 (peptidase inhibitor 16), as a secreted protein, is highly expressed in heart diseases such as heart failure. However, the functional role of PI16 in MI is unknown. This study aimed to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Luyang, Du, Anning, Lu, Yan, Zhao, Yunxi, Qiu, Ming, Su, Zhenyang, Shu, Huanyu, Shen, Hui, Sun, Wei, Kong, Xiangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227313/
https://www.ncbi.nlm.nih.gov/pubmed/37158154
http://dx.doi.org/10.1161/JAHA.122.028866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227313/
https://www.ncbi.nlm.nih.gov/pubmed/37158154
http://dx.doi.org/10.1161/JAHA.122.028866

Ejemplares similares